We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+3.99%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$124B
AUM Growth
-$818M
(-0.66%)
Cap. Flow
-$3.27B
Cap. Flow
% of AUM
-2.65%
Top 10 Holdings %
Top 10 Hldgs %
32.71%
Holding
4,253
New
85
Increased
832
Reduced
2,978
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 3000 ETF
IWV
|
+$588M |
| 2 |
CRH
CRH
|
+$47.1M |
| 3 |
Carvana
CVNA
|
+$34.4M |
| 4 |
Q
Qnity Electronics Inc
Q
|
+$33.9M |
| 5 |
Pinterest
PINS
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$326M |
| 2 |
Apple
AAPL
|
+$286M |
| 3 |
Microsoft
MSFT
|
+$251M |
| 4 |
MRSH
Marsh
MRSH
|
+$174M |
| 5 |
Amazon
AMZN
|
+$94.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.19% |
| 2 | Financials | 13.22% |
| 3 | Consumer Discretionary | 10.75% |
| 4 | Healthcare | 9.82% |
| 5 | Communication Services | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Gildan
GIL
$10.6B
| $85.8K | ﹤0.01% |
1,374
+105
| +8% | +$6.24K |
|
|
OPRA
3177
Opera Ltd
OPRA
$1.78B
| $84.9K | ﹤0.01% |
5,993
-281
| -4% | -$4.14K |
|
3178
Atomera
ATOM
$216M
| $84.6K | ﹤0.01% |
38,285
-3,061
| -7% | -$9.25K |
|
|
AUO
3179
DELISTED
AU Optronics Corp
AUO
| $83.6K | ﹤0.01% |
21,703
-703,182
| -97% | -$2.71M |
|
3180
iShares MSCI Germany ETF
EWG
$1.67B
| $83.5K | ﹤0.01% |
1,965
-1,140
| -37% | -$47.2K |
|
3181
Hanover Bancorp
HNVR
$192M
| $82.9K | ﹤0.01% |
3,587
-728
| -17% | -$16.2K |
|
3182
Korro Bio
KRRO
$197M
| $82.1K | ﹤0.01% |
10,250
+907
| +10% | +$21.2K |
|
3183
TIM SA
TIMB
$8.69B
| $81.9K | ﹤0.01% |
4,212
-5,810
| -58% | -$128K |
|
|
INV
3184
Innventure Inc
INV
$296M
| $81.5K | ﹤0.01% |
+19,488
| New | +$81.8K |
|
|
TLX
3185
Telix Pharmaceuticals
TLX
$4.06B
| $80.8K | ﹤0.01% |
10,787
+8,208
| +318% | +$79K |
|
3186
XPeng
XPEV
$11.2B
| $80.6K | ﹤0.01% |
3,974
-389
| -9% | -$8.44K |
|
3187
iShares S&P 100 ETF
OEF
$20.4B
| $79.9K | ﹤0.01% |
233
| – | – |
|
3188
Protalix BioTherapeutics
PLX
$211M
| $79.9K | ﹤0.01% |
44,369
-20,825
| -32% | -$42.6K |
|
|
BCYC
3189
Bicycle Therapeutics
BCYC
$284M
| $79.1K | ﹤0.01% |
11,171
+7,896
| +241% | +$58.2K |
|
|
SLN
3190
Silence Therapeutics
SLN
$641M
| $79K | ﹤0.01% |
12,999
+7,134
| +122% | +$45.7K |
|
3191
Telefônica Brasil
VIV
$18.5B
| $78.9K | ﹤0.01% |
6,655
-1,796
| -21% | -$22.3K |
|
3192
FitLife Brands
FTLF
$96.4M
| $78.6K | ﹤0.01% |
4,833
-1,037
| -18% | -$19.1K |
|
|
ATYR
3193
aTyr Pharma
ATYR
$53M
| $78.1K | ﹤0.01% |
99,762
-22,645
| -18% | -$18.6K |
|
|
IMMP
3194
Immutep
IMMP
$56.5M
| $77.6K | ﹤0.01% |
27,150
+5,318
| +24% | +$11.2K |
|
3195
Outset Medical
OM
$84.6M
| $77.6K | ﹤0.01% |
20,926
-3,390
| -14% | -$29.1K |
|
3196
SunPower Inc
SPWR
$46.4M
| $77.2K | ﹤0.01% |
49,203
-4,011
| -8% | -$6.9K |
|
3197
LifeVantage
LFVN
$82.1M
| $77K | ﹤0.01% |
12,494
-2,904
| -19% | -$21.5K |
|
3198
NLI Holdings
NL
$329M
| $75.6K | ﹤0.01% |
13,828
-9,719
| -41% | -$55.5K |
|
|
NNDM
3199
Nano Dimension
NNDM
$344M
| $75.5K | ﹤0.01% |
49,019
+5,649
| +13% | +$9.57K |
|
3200
Journey Medical
DERM
$177M
| $75.3K | ﹤0.01% |
9,761
-1,346
| -12% | -$10.6K |
|
Similar funds
RhumbLine Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, RhumbLine Advisers held 4,253 positions worth $124B, down 0.66% from $125B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 3.6%. RhumbLine Advisers opened 85 new positions and exited 67, leaving the 4,253-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q4 2025 buy was Qnity Electronics Inc: 399,119 shares worth $32.6M.
- RhumbLine Advisers added most to iShares Russell 3000 ETF in Q4 2025, an estimated $588M increase.
- RhumbLine Advisers's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $326M.
- RhumbLine Advisers fully exited Kellanova in Q4 2025, selling an estimated $52.6M.
- RhumbLine Advisers's ten largest holdings make up 33% of its $124B portfolio in Q4 2025.
- RhumbLine Advisers opened 85 new positions and closed 67 in Q4 2025.
- RhumbLine Advisers's portfolio value fell 0.66% quarter-over-quarter to $124B.
Based on RhumbLine Advisers's 13F filing for Q4 2025, filed 13 Feb 2026.